BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26079960)

  • 1. From traditional to whole-genome sequencing biomarkers for gastric cancer.
    Lianos GD; Bali CD; Katsios C; Roukos DH
    Biomark Med; 2015; 9(6):559-62. PubMed ID: 26079960
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of novel genes by whole-exome sequencing can improve gastric cancer precision oncology.
    Lianos GD; Glantzounis GK; Bali CD; Katsios C; Roukos DH
    Future Oncol; 2017 Apr; 13(10):883-892. PubMed ID: 27897040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites.
    Lim B; Kim C; Kim JH; Kwon WS; Lee WS; Kim JM; Park JY; Kim HS; Park KH; Kim TS; Park JL; Chung HC; Rha SY; Kim SY
    Oncotarget; 2016 Feb; 7(7):8055-66. PubMed ID: 26811494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From standard to new genome-based therapy of gastric cancer.
    Lianos GD; Mangano A; Cho WC; Roukos DH
    Expert Rev Gastroenterol Hepatol; 2015; 9(8):1023-6. PubMed ID: 26108988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
    Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
    Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer.
    Lim B; Kim JH; Kim M; Kim SY
    World J Gastroenterol; 2016 Jan; 22(3):1190-201. PubMed ID: 26811657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray and next-generation sequencing to analyse gastric cancer.
    Dang Y; Wang YC; Huang QJ
    Asian Pac J Cancer Prev; 2014; 15(19):8033-9. PubMed ID: 25338980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic heterogeneity: next-generation sequencing enables biomarker identification for hepatocellular carcinoma.
    Ziogas DE; Lykoudis EG; Roukos DH; Glantzounis GK
    Biomark Med; 2017 Jul; 11(7):515-518. PubMed ID: 28699774
    [No Abstract]   [Full Text] [Related]  

  • 9. Identifying molecular drivers of gastric cancer through next-generation sequencing.
    Liang H; Kim YH
    Cancer Lett; 2013 Nov; 340(2):241-6. PubMed ID: 23178814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The low-abundance transcriptome reveals novel biomarkers, specific intracellular pathways and targetable genes associated with advanced gastric cancer.
    Bizama C; Benavente F; Salvatierra E; Gutiérrez-Moraga A; Espinoza JA; Fernández EA; Roa I; Mazzolini G; Sagredo EA; Gidekel M; Podhajcer OL
    Int J Cancer; 2014 Feb; 134(4):755-64. PubMed ID: 23907728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A system level analysis of gastric cancer across tumor stages with RNA-seq data.
    Wu J; Zhao X; Lin Z; Shao Z
    Mol Biosyst; 2015 Jul; 11(7):1925-32. PubMed ID: 25924093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks.
    Roukos DH
    Pharmacogenomics J; 2011 Apr; 11(2):81-92. PubMed ID: 20975737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel signature for stratifying the molecular heterogeneity of the tissue-infiltrating T-cell receptor repertoire reflects gastric cancer prognosis.
    Kuang M; Cheng J; Zhang C; Feng L; Xu X; Zhang Y; Zu M; Cui J; Yu H; Zhang K; Yang A; Cheng S
    Sci Rep; 2017 Aug; 7(1):7762. PubMed ID: 28798410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
    Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
    Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach.
    Liu Z; Wang A; Pu Y; Li Z; Xue R; Zhang C; Xiang X; E JY; Bu Z; Bai F; Ji J
    Oncogene; 2021 Sep; 40(38):5705-5717. PubMed ID: 34326469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection.
    Shimizu T; Marusawa H; Matsumoto Y; Inuzuka T; Ikeda A; Fujii Y; Minamiguchi S; Miyamoto S; Kou T; Sakai Y; Crabtree JE; Chiba T
    Gastroenterology; 2014 Aug; 147(2):407-17.e3. PubMed ID: 24786892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
    Liu X; Wang J; Chen L
    Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gastric fluid proteome as a potential source of gastric cancer biomarkers.
    Wu W; Chung MC
    J Proteomics; 2013 Sep; 90():3-13. PubMed ID: 23665003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of recent next generation sequencing and the need for a new classification in gastric cancer.
    Businello G; Galuppini F; Fassan M
    Best Pract Res Clin Gastroenterol; 2021; 50-51():101730. PubMed ID: 33975684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-21: Mechanisms of Oncogenesis and its Application in Diagnosis and Prognosis of Gastric Cancer.
    Karimi Kurdistani Z; Saberi S; Tsai KW; Mohammadi M
    Arch Iran Med; 2015 Aug; 18(8):524-36. PubMed ID: 26265521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.